share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer McDermott Michael

SEC ·  Sep 17 01:00

Summary by Futu AI

Michael McDermott, Executive Vice President of Pfizer Inc [PFE], has been reported to engage in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to await further information for a complete understanding of the transaction's impact on their investment decisions.
Michael McDermott, Executive Vice President of Pfizer Inc [PFE], has been reported to engage in a transaction involving the company's stock on September 12, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and total value, have not been disclosed in the announcement. Investors are advised to await further information for a complete understanding of the transaction's impact on their investment decisions.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.